{"url_path":"/sec/codx/8-k/2026-05-14/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1692415/0001493152-26-023059-index.html","accession_number":"0001493152-26-023059","cik":"0001692415","ticker":"CODX","issuer_name":"Co-Diagnostics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1692415/0001493152-26-023059-index.html","primary_entity_key":"0001692415","primary_entity_name":"Co-Diagnostics, Inc."},"word_count":151,"has_tables":true,"body_markdown":"** **\n\n**Item\n2.02. Results of Operations and Financial Condition.**\n\n \n\nOn\nMay 14, 2026, Co-Diagnostics, Inc. (the “Company”) issued a press release announcing financial results for its quarter ended\nMarch 31, 2026. The full text of the press release, which includes information regarding the Company’s use of a non-GAAP financial\nmeasure, is furnished as Exhibit 99.1 to this Form 8-K.\n\n \n\nThe\ninformation contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed”\nfor the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section. Furthermore,\nthe information contained in this Item 2.02 or Exhibit 99.1 shall not be deemed to be incorporated by reference into any registration\nstatement or other document filed pursuant to the Securities Act of 1933, except as shall be expressly set forth by specific reference\nin such filing."}